Analyst Ratings For Core Laboratories N.V. (NYSE:CLB)
Today, Scotiabank reiterated its Hold rating on Core Laboratories N.V. (NYSE:CLB) with a price target of $136.00.
There are 1 sell rating, 7 hold ratings, 5 buy ratings on the stock.
The current consensus rating on Core Laboratories N.V. (NYSE:CLB) is Hold (Score: 2.31) with a consensus target price of $111.00 per share, a potential 18.31% upside.
Some recent analyst ratings include
- 10/25/2017-Scotiabank Reiterated Rating of Hold.
- 10/18/2017-Royal Bank Of Canada Reiterated Rating of Buy.
- 10/10/2017-Deutsche Bank AG initiated coverage with a Buy rating.
- 8/24/2017-Credit Suisse Group Upgrade from a “Neutral ” rating to a ” Outperform” rating.
Dividend information for Core Laboratories N.V. (NYSE:CLB)
Core Laboratories N.V. (NYSE:CLB) pays an annual dividend of Community Ranking: with a yield of 2.34% and an average dividend growth of 19.80% based on a 3 Year Average.
Dividend History for Core Laboratories N.V. (NYSE:CLB)
- On 10/10/2017 Core Laboratories N.V. announced a quarterly dividend of $0.55 with an ex dividend date of 10/19/2017 which will be payable on 11/21/2017.
- On 7/6/2017 Core Laboratories N.V. announced a Quarterly dividend of $0.55 2.11% with an ex dividend date of 7/13/2017 which will be payable on 8/14/2017.
- On 4/19/2017 Core Laboratories N.V. announced a quarterly dividend of $0.55 1.98% with an ex dividend date of 4/27/2017 which will be payable on 5/23/2017.
- On 1/10/2017 Core Laboratories N.V. announced a Quarterly dividend of $0.55 1.8% with an ex dividend date of 1/18/2017 which will be payable on 2/17/2017.
- On 10/11/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 1.95% with an ex dividend date of 10/19/2016 which will be payable on 11/22/2016.
- On 7/7/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 with an ex dividend date of 7/14/2016 which will be payable on 8/15/2016.
- On 4/15/2016 Core Laboratories N.V. announced a Quarterly dividend of $0.55 with an ex dividend date of 5/2/2016 which will be payable on 5/24/2016.
- On 2/1/2017 Michael Straughen, Director, bought 106 with an average share price of $118.65 per share and the total transaction amounting to $12,576.90. View SEC Filing
- On 1/30/2017 Martha Z Carnes, Director, bought 200 with an average share price of $115.20 per share and the total transaction amounting to $23,040.00. View SEC Filing
- On 2/2/2016 Jan Willem Sodderland, Director, bought 300 with an average share price of $93.90 per share and the total transaction amounting to $28,170.00. View SEC Filing
- On 5/12/2015 Michael C Kearney, Director, sold 1,000 with an average share price of $128.52 per share and the total transaction amounting to $128,520.00. View SEC Filing
- On 11/17/2014 Mark F Elvig, VP, sold 1,000 with an average share price of $138.03 per share and the total transaction amounting to $138,030.00. View SEC Filing
- On 7/28/2014 Richard L Bergmark, CFO, bought 7,000 with an average share price of $147.31 per share and the total transaction amounting to $1,031,170.00. View SEC Filing
- On 3/7/2014 Michael Kearney, Director, sold 2,000 with an average share price of $193.00 per share and the total transaction amounting to $386,000.00. View SEC Filing
Recent Trading Activity for Core Laboratories N.V. (NYSE:CLB)
Shares of Core Laboratories N.V. closed the previous trading session at with shares trading hands.